课题基金 / 基金详情

Development of a Novel Method for the Identification and Characterization of Intercellular Communication in the Cancer Niche

Development of a Novel Method for the Identification and Characterization of Intercellular Communication in the Cancer Niche
开发一种用于识别和表征癌症生态位中细胞间通讯的新方法
批准号:
10426930
负责人:
PETER M GORDON
金额:
$7.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2024-08-31

项目摘要

项目成果

PETER M GORDON的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
ABSTRACT Intercellular interactions and communication between cancer cells the cells that comprise their niches are critical for many aspects of cancer development, progression, metastasis, and therapy resistance. These interactions are often dynamic, transient and complex. Moreover, intercellular communication occurs directly by contact dependent cell-cell interactions and indirectly by the secretion of soluble factors into the local microenvironment. Current limitations to proximity dependent labeling strategies designed to identify and characterize direct and indirect cellular interaction partners in vivo include reagents that are toxic and/or limit the isolation and subsequent characterization of interacting cells, non-specific or large radius labeling (i.e. direct vs. indirect contacts), or a requirement to pre-engineer both interacting cells which obviates the possibility of identifying novel cellular interaction partners. Thus, a more ideal in vivo proximity dependent labeling system would concurrently, but differentially, label both direct and indirect cellular contacts at multiple timepoints using technology that is compatible with an array of downstream analyses ranging from microscopy to single cell analyses. In this proposal we will address this shortcoming in current technologies for comprehensively identifying and characterizing direct and indirect intercellular interactions in vivo. We will build upon the literature and our preliminary work to develop a novel approach in which an engineered cancer cell, or other cell of interest, concurrently, differentially and temporally fluorescently labels both direct and indirect cellular contacts within the cancer niche (Aims 1 and 2). Importantly, labeled cells will be suitable for an array of downstream analyses such as microscopy, flow cytometry, and cell sorting followed by bulk or single cell analyses. Accordingly, as proof-of-concept we will then combine this niche labeling technology with single-cell RNA-seq to begin to define cellular contacts during early stages of central nervous system leukemia metastasis and niche development (Aim 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
  • 批准号:
    10651082
  • 项目类别:
  • 资助金额:
    $21.87万
  • 财政年份:
    2023
  • 负责人:
    PETER M GORDON
  • 依托单位:
Overcoming Leukemia Chemoresistance in the Central Nervous System
  • 批准号:
    10591475
  • 项目类别:
  • 资助金额:
    $34.52万
  • 财政年份:
    2020
  • 负责人:
    PETER M GORDON
  • 依托单位:
Overcoming Leukemia Chemoresistance in the Central Nervous System
  • 批准号:
    10357911
  • 项目类别:
  • 资助金额:
    $35.23万
  • 财政年份:
    2020
  • 负责人:
    PETER M GORDON
  • 依托单位:
Autophagy and Apoptosis in the Response of c-KIT Cancers to Targeted Therapy
  • 批准号:
    8913061
  • 项目类别:
  • 资助金额:
    $14.34万
  • 财政年份:
    2011
  • 负责人:
    PETER M GORDON
  • 依托单位:
海外基金